Companies Dominating the Pelvic Organ Prolapse Repair Landscape
- Johnson & Johnson Services, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Coloplast Pty Ltd.
- Boston Scientific Corporation
- CooperSurgical, Inc.
- Dr. Arabin GmbH & Co. KG
- Integra LifeSciences,
- Utah Medical Products, Inc.
- Shenzhen XFT Medical Limited
- Nuvo Group Ltd
- Sunmedix Co, Ltd.
- Verity Medical Ltd
- HealthVerity, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of pelvic organ prolapse repair is evaluated at USD 459.22 million.
The pelvic organ prolapse repair market size was over USD 441.22 million in 2024 and is poised to exceed USD 811.62 million by 2037, witnessing over 4.8% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of pelvic organ prolapse (POP) in the female population across the globe and growing development of advanced and new pelvic organ prolapse repair devices will drive the market growth.
North America industry is anticipated to account for largest revenue share of 41% by 2037, impelled by rising spending in the healthcare sector in the region.
The major players in the market are CooperSurgical, Inc., Dr. Arabin GmbH & Co. KG, Integra LifeSciences, Utah Medical Products, Inc., Shenzhen XFT Medical Limited, Sunmedix Co, Ltd., Verity Medical Ltd, Neomedic, and Johnson & Johnson Services, Inc., Coloplast Pty Ltd, Boston Scientific Corporation, and others.
